{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:59:33Z","timestamp":1790719173176,"version":"4.1.0"},"reference-count":25,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A candidate vaccine against botulinum neurotoxin serotype A (BoNT\/A) was developed by using a Venezuelan equine encephalitis (VEE) virus replicon vector. This vaccine vector is composed of a self-replicating RNA containing all of the VEE nonstructural genes and\n            <jats:italic>cis<\/jats:italic>\n            -acting elements and also a heterologous immunogen gene placed downstream of the subgenomic 26S promoter in place of the viral structural genes. In this study, the nontoxic 50-kDa carboxy-terminal fragment (H\n            <jats:sub>C<\/jats:sub>\n            ) of the BoNT\/A heavy chain was cloned into the replicon vector (H\n            <jats:sub>C<\/jats:sub>\n            -replicon). Cotransfection of BHK cells in vitro with the H\n            <jats:sub>C<\/jats:sub>\n            -replicon and two helper RNA molecules, the latter encoding all of the VEE structural proteins, resulted in the assembly and release of propagation-deficient, H\n            <jats:sub>C<\/jats:sub>\n            VEE replicon particles (H\n            <jats:sub>C<\/jats:sub>\n            -VRP). Cells infected with H\n            <jats:sub>C<\/jats:sub>\n            -VRP efficiently expressed this protein when analyzed by either immunofluorescence or by Western blot. To evaluate the immunogenicity of H\n            <jats:sub>C<\/jats:sub>\n            -VRP, mice were vaccinated with various doses of H\n            <jats:sub>C<\/jats:sub>\n            -VRP at different intervals. Mice inoculated subcutaneously with H\n            <jats:sub>C<\/jats:sub>\n            -VRP were protected from an intraperitoneal challenge of up to 100,000 50% lethal dose units of BoNT\/A. Protection correlated directly with serum enzyme-linked immunosorbent assay titers to BoNT\/A. The duration of the immunity achieved was tested at 6 months and at 1 year postvaccination, and mice challenged at these times remained refractory to challenge with BoNT\/A.\n          <\/jats:p>","DOI":"10.1128\/iai.69.9.5709-5715.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:40Z","timestamp":1027764220000},"page":"5709-5715","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":47,"title":["Candidate Vaccine against Botulinum Neurotoxin Serotype A Derived from a Venezuelan Equine Encephalitis Virus Vector System"],"prefix":"10.1128","volume":"69","author":[{"given":"John S.","family":"Lee","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Virology Division1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pushko","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Virology Division1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Parker","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Virology Division1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Dertzbaugh","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Toxinology Division,2 U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Toxinology Division,2 U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan F.","family":"Smith","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Virology Division1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)38824-6"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.10.4817-4822.1998"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00253-4"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.7.2738-2742.1995"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.6.3781-3787.1996"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.1.371-378.2000"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.8.3253"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Hatheway\nC. L.\nBotulism\nLaboratory diagnosis of infectious diseases: principles and practice.\nBalows\nA.\nHausler\nJ. W. J.\nOhashi\nM.\nTurano\nA.\n1988\n111\n133\nSpringer-Verlag Inc.\nNew York N.Y","DOI":"10.1007\/978-1-4612-3898-0_12"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00126-7"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9367"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90079-D"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1291-1356"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.24.10191"},{"key":"e_1_3_1_15_2","unstructured":"Pushko\nP.\nParker\nM.\nGeisbert\nJ.\nNegley\nD.\nSchmaljohn\nA.\nJahrling\nP.\nSmith\nJ.\nVenezuelan equine encephalitis virus replicon vector: immunogenicity studies with Ebola NP and GP genes in guinea pigs.\n1997\nCold Spring Harbor Laboratory Press\nCold Spring Harbor N.Y"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8878"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.12.7391-7401.1995"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.7.1461"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02255918"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(98)00146-9"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","unstructured":"Strauss\nE. G.\nStrauss\nJ. H.\nStructure and Replication of the alphavirus genome\nThe Togaviridae and the Flaviviridae.\nSchlesinger\nS.\nSchlesinger\nM.\n1986\n35\n90\nPlenum Press\nNew York N.Y","DOI":"10.1007\/978-1-4757-0785-4_3"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.58.3.491-562.1994"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.44.3.419-448.1980"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Tacket\nC. O.\nRogawski\nM. A.\nBotulism\nBotulinum neurotoxin and tetanus toxin.\nSimpson\nL. L.\n1989\n351\n378\nAcademic Press Inc.\nSan Diego Calif","DOI":"10.1016\/B978-0-12-644445-2.50024-6"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15461.x"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.8.4017-4025.1991"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.9.5709-5715.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.9.5709-5715.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:40:58Z","timestamp":1646487658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.9.5709-5715.2001"}},"subtitle":[],"editor":[{"given":"J. T.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1128\/IAI.69.9.5709-5715.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.9.5709-5715.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"2001-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}